Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by Danone Trading ELN B.V
| dc.contributor.author | EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) | |
| dc.contributor.institution | University of Aberdeen.Rowett Institute | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
| dc.date.accessioned | 2021-05-12T20:17:01Z | |
| dc.date.available | 2021-05-12T20:17:01Z | |
| dc.date.issued | 2020-11-28 | |
| dc.description | Acknowledgments: The Panel also wishes to thank the following EFSA staff members for the support provided to this scientific output: Domenico Azzolini, Ester Artau Cortacans, Federico Morreale, Charlotte Salgaard Nielsen and Ermolaos Ververis. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 12 | |
| dc.format.extent | 1338457 | |
| dc.identifier | 191209345 | |
| dc.identifier | 4f1124f8-3d7f-4626-95d0-a447b4de9bc5 | |
| dc.identifier | 33312234 | |
| dc.identifier | 85097084370 | |
| dc.identifier.citation | EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) 2020, 'Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by Danone Trading ELN B.V', EFSA Journal, vol. 18, no. 11, e06304. https://doi.org/10.2903/j.efsa.2020.6304 | en |
| dc.identifier.doi | 10.2903/j.efsa.2020.6304 | |
| dc.identifier.iss | 11 | en |
| dc.identifier.issn | 1831-4732 | |
| dc.identifier.other | PubMedCentral: PMC7698673 | |
| dc.identifier.other | ORCID: /0000-0002-9275-9713/work/99981875 | |
| dc.identifier.uri | https://hdl.handle.net/2164/16453 | |
| dc.identifier.vol | 18 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | EFSA Journal | en |
| dc.subject | Protein hydrolysate | en |
| dc.subject | characterisation | en |
| dc.subject | formula | en |
| dc.subject | nutritional safety | en |
| dc.subject | suitability | en |
| dc.subject | clinical trial | en |
| dc.subject | infants | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by Danone Trading ELN B.V | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- EFSApanel_nutritional_safety_and_VOR.pdf
- Size:
- 1.28 MB
- Format:
- Adobe Portable Document Format
